Pharmaceutical Companies; Patent Issued for 4-Pyridinone Compounds and Their Use for Cancer
Pharmaceutical Companies; Patent Issued for 4-Pyridinone Compounds and Their Use for Cancer
About this item
Full title
Publisher
Atlanta: NewsRx
Journal title
Language
English
Formats
Publication information
Publisher
Atlanta: NewsRx
More information
Scope and Contents
Contents
URL and more information on this patent, see: [Borzilleri], Robert M.; Cai, Zhen-Wei. 4-Pyridinone Compounds and Their Use for Cancer. U.S. Patent Number 8258118, filed January 12, 2012, and issued September 4, 2012. Patent URL: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=74&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=3673&f=G&l=50&co1=AND&d=PTXT&s1=20120904.PD.&OS=ISD/20120904&RS=ISD/20120904 "Applicants have found a potent compound that has activity against cancers dependent upon Met activation and also has activity against cancers as a VEGFR inhibitor. Applicants have also discovered prodrugs of the compound useful for administration of the compound in a more soluble form. It is now possible to provide compounds with different ph...
Alternative Titles
Full title
Pharmaceutical Companies; Patent Issued for 4-Pyridinone Compounds and Their Use for Cancer
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_1039065104
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1039065104
Other Identifiers
ISSN
1535-2757
E-ISSN
1537-1395